Genolution Inc. (KOSDAQ:225220)
South Korea · Delayed Price · Currency is KRW 1,501.00
+21.00 (1.42%)
At close: Oct 21, 2026
Genolution Revenue
Genolution had revenue of 3.09B KRW in the quarter ending June 30, 2026, with 7.29% growth. This brings the company's total for the last twelve months to 10.03B, up 14.42% year-over-year. In the year 2025, Genolution had annual revenue of 9.40B with 31.79% growth. That makes Genolution the 38,488th largest company in the world by revenue and 2,432nd in South Korea.
Revenue (ttm)
10.03B
Revenue Growth
+14.42%
P/S Ratio
2.70
Revenue / Employee
139.32M
Employees
72
Market Cap
27.12B
Revenue by Geography
- South Korea 7.62B 81.0%
- Overseas 1.79B 19.0%
Fiscal year ended Dec 31, 2025 See the full Genolution breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.40B | 2.27B | 31.79% |
| Dec 31, 2024 | 7.14B | -2.63B | -26.90% |
| Dec 31, 2023 | 9.76B | -28.32B | -74.37% |
| Dec 31, 2022 | 38.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.